Zinc transporter SLC39A13/ZIP13 facilitates the metastasis of human ovarian cancer cells via activating Src/FAK signaling pathway

Table 2 Association of ZIP13 expression with clinicopathological characteristics in ovarian cancer

Clinicopathological characteristics	Total	ZIP13 expression		χ²	P
Clinicopathological characteristics	N = 139	Low	High	χ²	P
Age, years				0.64	0.424
<60	103	30	73
≥60	36	8	28
Sample type				1.802	0.179
Primary tumor	126	37	89
Recurrence/metastasis tumor	13	1	12
Histological/Histologic subtype				4.662	0.031
Serous carcinoma	86	18	68
Non-serous carcinoma	53	20	33
Tumor size, cm				1.522	0.217
<5	40	8	32
≥5	99	30	69
Primary tumor stage				1.999	0.157
T1/T2	39	14	25
T3/T4	100	24	76
Lymphatic metastasis				8.499	0.004
No	99	34	65
Yes	40	4	36
Distant metastasis				9.306	0.002
No	107	36	71
Yes	32	2	30
FIGO stage				1.999	0.157
I/II	39	14	25
III/IV	100	24	76

ISSN: 1756-9966